LRSAM1 mutations have been found in recessive and dominant forms of Charcot-Marie-Tooth disease. Within one generation of the original Dutch family in which the dominant LRSAM1 mutation was identified, three of the five affected family members have developed Parkinson's disease between ages 50 and 65 years, many years after neuropathy onset. We speculate that this late-onset parkinsonism is part of the LRSAM1 phenotype, thus associating a hitherto peripheral nerve disease with a central nervous system phenotype. How the mutated Lrsam1 protein, which normally has E3 ubiquitin ligase activity and is expressed in the nervous system, impacts on substantia nigra neurons is unclear.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748314 | PMC |
http://dx.doi.org/10.1002/acn3.281 | DOI Listing |
Clin Neurol Neurosurg
February 2024
Neurology Unit, ASL Bari, San Paolo Hospital, Bari, Italy; Center for Neurodegenerative Diseases and the Aging Brain at Pia Fondazione "G. Panico", University of Bari Aldo Moro, Tricase (Lecce), Italy. Electronic address:
Charcot-Marie-Tooth disease type 2P (CMT2P; MIM #614436) is a specific type of axonal neuropathy caused by mutations in the LRSAM1 gene, which is a RING-type E3 ubiquitin ligase. CMT2P can be inherited in two ways: as an autosomal dominant or autosomal recessive trait. In this report, we describe the clinical characteristics of a family with axonal sensory-motor neuropathy caused by a new variant of the LSRAM1 gene, which is associated with early-onset autosomal dominant CMT2P.
View Article and Find Full Text PDFJ Peripher Nerv Syst
December 2023
Neurogenetics Unit, 1st Department of Neurology, Eginition Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Background And Aims: Axonal forms of Charcot-Marie-Tooth disease (CMT) are classified as CMT2, distal hereditary motor neuropathy (dHMN) or hereditary sensory neuropathy (HSN) and can be caused by mutations in over 100 genes. We presently aimed to investigate for the first time the genetic landscape of axonal CMT in the Greek population.
Methods: Sixty index patients with CMT2, dHMN or HSN were screened by a combination of Sanger sequencing (GJB1) and next-generation sequencing custom-made gene panel covering 24 commonly mutated genes in axonal CMT.
Zhonghua Nei Ke Za Zhi
August 2022
Neurological Department of the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Charcot-Marie-Tooth disease (CMT) comprises a group of clinically and genetically heterogeneous inherited neuropathies with an estimated prevalence of 1 in 2500. This study aimed to analyze the clinical and mutational characteristics of Chinese CMT patients with MFN2, BSCL2 and LRSAM1 variants. In this study, genetic analysis was performed in 206 Chinese patients at Chinese PLA General Hospital from December 2012 to March 2020 with clinical diagnosis of CMT, and reported variants of MFN2, BSCL2 and LRSAM1 related to CMT2.
View Article and Find Full Text PDFSci Rep
July 2022
Department of Neurology, Wayne State University School of Medicine, Detroit, MI, USA.
Missense mutation C694R in the RING domain of the LRSAM1 gene results in a dominantly inherited polyneuropathy, Charcot-Marie-Tooth disease type 2P (CMT2P). We have generated and characterized a Lrsam1 knock-in mouse model produced through CRISPR/Cas9 technology. Both heterozygous (Lrsam1) and homozygous (Lrsam1) knock-in mice exhibited normal motor functions on behavioral tests as well as normal on nerve conduction studies.
View Article and Find Full Text PDFJ Neuroophthalmol
December 2023
John A. Moran Eye Center (NM, SV, MDS), University of Utah, Salt Lake City, Utah; and Oakland Univrsity William Beaumont School of Medicine (DR), Rochester, Michigan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!